Figures & data
Table 1 Baseline characteristics of the subjects of the first group
Table 2 Characteristics of the AECOPD subjects in the second group
Figure 1 Serum IGFBP7 concentrations in patients with AECOPD in ICU, not in ICU, and healthy control subjects in the first group.
![Figure 1 Serum IGFBP7 concentrations in patients with AECOPD in ICU, not in ICU, and healthy control subjects in the first group.](/cms/asset/85af7ca7-9048-40cd-a9fd-6d31ed1b6c7e/dcop_a_132652_f0001_b.jpg)
Figure 2 Serum IGFBP7 and CRP concentrations during exacerbations and after clinical improvement in AECOPD patients in the second group.
Abbreviations: AECOPD, acute exacerbation of chronic obstructive pulmonary disease; IGFBP7, insulin-like growth factor binding protein 7; ICU, intensive care unit; CRP, C-reactive protein.
![Figure 2 Serum IGFBP7 and CRP concentrations during exacerbations and after clinical improvement in AECOPD patients in the second group.](/cms/asset/315d5f7f-7ef9-4a35-8496-cbfae7766b86/dcop_a_132652_f0002_b.jpg)
Figure 3 Correlation of serum IGFBP7 levels with CRP levels in patients with COPD exacerbations in the second group.
Abbreviations: IGFBP7, insulin-like growth factor binding protein 7; CRP, C-reactive protein; COPD, chronic obstructive pulmonary disease.
![Figure 3 Correlation of serum IGFBP7 levels with CRP levels in patients with COPD exacerbations in the second group.](/cms/asset/d56ad997-01a2-4ac1-8733-e461db94cda0/dcop_a_132652_f0003_b.jpg)
Figure 4 ROC curve for IGFBP7 and CRP in discrimination of AECOPD patients on the admission day and discharge day in the second group.
![Figure 4 ROC curve for IGFBP7 and CRP in discrimination of AECOPD patients on the admission day and discharge day in the second group.](/cms/asset/4f7f6533-dcdd-4cae-9d8e-d6f33da738c6/dcop_a_132652_f0004_b.jpg)